Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Ahn_Jae-yong
|
| gptkbp:collaboratedWith |
gptkb:AstraZeneca
gptkb:Bill_&_Melinda_Gates_Foundation |
| gptkbp:country |
gptkb:South_Korea
|
| gptkbp:developedBy |
SKYCellflu
SKYCovione SKYZoster |
| gptkbp:foundedYear |
2018
|
| gptkbp:headquartersLocation |
gptkb:Seongnam,_South_Korea
|
| https://www.w3.org/2000/01/rdf-schema#label |
SK Bioscience (South Korea)
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:listedOn |
gptkb:KOSPI
|
| gptkbp:notableEvent |
Developed COVID-19 vaccine candidate during the pandemic
|
| gptkbp:parentCompany |
gptkb:SK_Group
|
| gptkbp:product |
vaccine
vaccines cell culture-based influenza vaccine |
| gptkbp:stockSymbol |
302440.KS
|
| gptkbp:website |
https://www.skbioscience.co.kr
|
| gptkbp:bfsParent |
gptkb:Novavax_COVID-19_vaccine
|
| gptkbp:bfsLayer |
5
|